The Piedmont Triad Regenerative Medicine Engine (PTRME) welcomes our newest ecosystem partner, GeisterBio! This early-stage startup is driving innovation in 3D bioprinting with its multi-material printhead technology to advance tissue engineering and organ fabrication. Their cutting-edge technology is designed to enhance speed, flexibility, and cost efficiency in regenerative medicine.
At GeisterBio, the vision is clear: a future where no patient waits for a life-saving organ. Committed to transforming organ transplantation, GeisterBio is pioneering bioprinting technology to enable personalized medicine. By delivering state-of-the-art solutions, they empower scientific discovery, accelerate medical advancements, and improve lives on a global scale.
PTRME Ecosystem Partner Advancing the Future of Bioprinting:
✅ Next-Generation Technology – Developing novel bioprinting solutions to support research in tissue engineering and organ fabrication.
✅ Collaborative Innovation – Partnering with startups, researchers, and clinicians to accelerate progress in regenerative medicine.
✅ Expanding Accessibility – Committed to making advanced bioprinting more accessible for researchers, clinicians, and industry leaders.
GeisterBio’s advanced 3D bioprinter will soon be part of the PTRME Test Bed, offering new opportunities for collaboration and discovery in regenerative medicine. Stay tuned for more ecosystem partner updates!